Navigation Links
Lifetime risk of heart failure increases

A person aged 40 or over has a lifetime risk of heart failure of one in five, which is doubled if they have high blood pressure. Heart failure is an increasing problem, as the population ages. //It's caused by increasing pressure within the heart which makes it hard to pump blood around the body. Typical symptoms are breathlessness and fatigue and the condition is very disabling.

Researchers for the Framingham Heart Study have been looking at the rates of heart failure over a 24 year time period in a group of over 7,050 men and women. For women, the lifetime risk of heart failure if they had no history of heart attack was one in six. For all women, the risk is one in five - from age 40. For men, the risk without heart attack was one in nine, and overall the same as women - one in five. This suggests that previous heart attack does raise the risk of heart failure.

Similar trends were also found for those who have high blood pressure - which roughly doubles the risk of heart failure for both men and women. The study strongly suggests that reducing high blood pressure and heart attack risk will also reduce rates of heart failure.


'"/>




Page: 1

Related medicine news :

1. New Flu Vaccine Can Give Lifetime Protection
2. Encouraging a Lifetime of Healthy Skin Right from the Beginning
3. Drug Therapy can Reduce Preterm Births and Decrease Lifetime Medical Costs
4. Starvation in pregnant women can cause heart disease to their children
5. Individuals with sleep related breathing disorders more prone to heart disease
6. And now they say infections can cause heart disease!!!!
7. And now they say infections can cause heart disease!!!!
8. Award for TTK Chitra heart valve prosthesis
9. Eat greens to have a ever green heart
10. Asthma! A new warning for heart disease
11. Protein in urine foresees heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lifetime risk heart failure increases

(Date:10/10/2008)...g as tipping point for behavior change, DES MOINE...an half of,Americans (51 percent) believe there ar..., but major changes are needed, according to the 2...released today by the,Employee Benefit Research In...and was underwritten by the Principal Financial Gr...
(Date:10/10/2008).../PRNewswire/ -- NuView Life Sciences Inc.,(NuView)...ences Inc.,(Trace), including operations of the li...es in Denton, Texas. The Trace facility produces,C...hallium-201 used in,molecular imaging and nuclear ...ted that "We are confident that by improving opera...
(Date:10/10/2008)...RNewswire-USNewswire/ -- Public interest,advocates...ned to make,decisions on the threats posed by merc...er 2008, the 2nd UNEP(2) Open Ended Working Group ...ld form part of a global framework,on mercury, in ... February,2009, where it will be decided whether a...
(Date:10/10/2008)...could lessen long-term side effects, study finds ...Using chemotherapy alone, and delaying or avoiding...g children with inoperable or progressive low-grad...utional study. , Low-grade glioma is the most c...erformed, the survival rate for patients is 95 per...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Elements for a UN Global Framework on Mercury Agreed to 2Health News:Chemo Alone Effective in Treating Kids' Brain Tumors 2
... girls are six times more likely to have a Body Ma...ears ago and //ten-year-olds are five times more l...l issue of Acta Paediactrica. Swedish researchers... a thousand children over two decades discovered t...
... of diabetes among indigenous people is not due to...ublished study// . The study was authored by Dr Y...es School of Health Research along with two resear... that the high rates of diabetes among indigenous ...
... and Drug Administration (FDA) is alerting consume...olives that may be contaminated with a deadly bact...se botulism, a potentially fatal illness. The oliv...i S.r.l, of Bari, Italy and are being recalled by ...
...an’s daily calcium intake is an effective way of i...than average risk of osteoporosis, according to a ...ity School of Medicine, Barcelona, Spain, looked a...tate cancer. 72 per cent were receiving androgen-d...
Other Medicine News:Health News:20-year Study Shows Significant Rise in Childhood Obesity, Especially Among Girls 2Health News:FDA Urgently Warns Consumers About Health Risks of Potentially Contaminated Olives 2Health News:Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient 2
(Date:10/9/2008)...e Clinical Results Expected in November 2008, BOT...R Pharma, Inc.,(Amex: DDD ) announced today the c... third of its three pivotal trials to evaluate the... extended-release (ER) ibuprofen for,the over-the-...t top-line,results from this pivotal trial in Nove...
(Date:10/8/2008)...ngs May Someday Inform Treatments for Spinal Cord,...Newswire-USNewswire/ -- A protein that enables,ner...y role in controlling,the developing nervous syste...nnections to form among nerve cells may provide a ...fer injuries to their nervous system,including sp...
(Date:10/8/2008)...indings Confirm Potency of Poly-ICR as Vaccine Adj...- Nventa Biopharmaceuticals,Corporation (TSX: NVN)...udies using its proprietary Toll-like Receptor 3 a...orld Vaccine Congress 2008 in Lyon, France.,Study ...ne adjuvant,targeting the Toll-like Receptor 3 (TL...
(Date:10/7/2008)...ates the efficacy of new device for detecting poly... colonoscopy, ORLANDO, Fla., Oct. 7 /PRNewswire/ ...ual Scientific Meeting in Orlando (ACG 2008), reno...ed results from a,multi-institutional clinical stu... Retroscope(R), a new device that is designed to i...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Toll Free Hotline to Help Seniors Avoid Falls 10813 1Toll Free Hotline to Help Seniors Avoid Falls 10813 2SEIU Healthcare Workers to Appeal During Super Bowl for Free and Fair Union Elections in Boston Hospitals 10811 1SEIU Healthcare Workers to Appeal During Super Bowl for Free and Fair Union Elections in Boston Hospitals 10811 2New strategy helps reduce errors in obstetrical care 10809 1New strategy helps reduce errors in obstetrical care 10809 2Stars Don Red to Raise Awareness of Womens Heart Risk 10807 1Stars Don Red to Raise Awareness of Womens Heart Risk 10807 2Stars Don Red to Raise Awareness of Womens Heart Risk 10807 3
..., 2007) Nymox Pharmaceutical,Corporation (NASDAQ: ...he Company’s recently completed studies of N... be presented at a series of,upcoming U.S. urology...tral American Urological Association Meeting in Co...ions will be given by,leading clinical research ur...
...itic cells with tumor lysate,triggers robust antig...YOKOHAMA, Japan, June 22, 2007,/PRNewswire/ -- Max...poster presentation at the 13th Annual Meeting of ...e meeting is being,held June 24-27, 2007 in Sydney...roloading of mature dendritic,cells with tumor lys...
Other Medicine Technology:Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 2Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S.,Urology Meetings 3MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 3
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base.
Certified by an independent laboratory to meet Class 100 specifications of Federal Standard 209E. Ergonomic seat guarantees worker confort, reduces fatique and back injuries. Clean vinyl meets Class
Inquire
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in.
Medicine Products: